Introduction
============

Brain damage can directly lead to mental disorders. Abnormalities in gray matter of the frontal lobe are found in schizophrenia patients.[@b1-ndt-15-721] The central nervous system is composed of neurons and glial cells; the former is mainly responsible for the transmission and processing of information, while the latter supports neurons and plays a role in protection, nutrition, and formation of myelin sheath and repair.[@b2-ndt-15-721] Neurons send signals through synaptic connections, and there is approximately one teraflop of brain operation occurring in the synaptic connections, forming a number of neural circuits that underlie mental and neural activity. Once these brain regions are changed, the individual may show noticeable psychiatric symptoms.[@b3-ndt-15-721]--[@b5-ndt-15-721]

Schizophrenia has a major genetic component, and it is both etiologically and clinically complex. A genome-wide association study found that the single-nucleotide polymorphism rs1344706 of the zinc finger protein 804A (*ZNF804A*) gene is associated with schizophrenia. The alleles of rs1344706 result in differential prediction of the presence of binding sites for two brain-expressed transcription factors. The MYT1L zinc finger protein is expressed in neural progenitors along with the related family member MYT1 (which is known to modulate proliferation and terminal differentiation of oligodendrocyte progenitors).[@b6-ndt-15-721] Of note, the *MYT1L* gene was included in a copy number variant observed in an affected individual in a recent study of structural variation in schizophrenia. The POU3F1/Oct-6 POU domain transcription factor is involved in oligodendrocyte differentiation and the transition of promyelinating to myelinating Schwann cells and is also normally expressed in adult cortex and hippocampus.[@b6-ndt-15-721] Researchers use "imaging genetics" to explore the relationship between the risk gene and brain structural changes in patients with mental disorders. Lencz et al[@b7-ndt-15-721] investigated the effect of *ZNF804A*, a risk gene for schizophrenia, on neuroanatomy and neurocognitive phenotypes. They found that healthy individuals with homozygous risk allele T have larger overall white matter and smaller gray matter compared with C allele carriers. This phenotype may directly reflect altered neural connection status. Wassink et al[@b8-ndt-15-721] found that rs1344706 has a significant effect on total, frontal, and parietal white matter content in patients with schizophrenic spectrum diseases and their health.

Although there is a number of evidence to support the influence of the *ZNF804A* gene on the brain structure of healthy individuals and those with mental disorders, they are inconsistent. There is still a lack of meta-analysis to comprehensively evaluate these disparate findings. Therefore, the aim of this study was to explore the relationship between brain structure and the *ZNF804A* gene rs1344706 polymorphism based on a signed difference map. It also provides a reference for studying genetic-related mechanisms of mental disorders such as schizophrenia.

Materials and methods
=====================

Study design
------------

The study was designed using voxel-based and general meta-analysis methods based on clinical data of statistical maps, peak coordinates, and statistical effect size collected from previous association studies of brain structural changes and *ZNF804A* gene polymorphisms. Two researchers (SW and YH) independently reviewed the literature and selected studies to use in the meta-analysis. Any disagreement was resolved through a group discussion.

Searching strategies
--------------------

Literature searches were performed in databases including Medline, ScienceDirect, and Scopus before December 2017. The following search terms were combined and used: "ZNF804A/rs1344706" and "MRI/structural MRI/sMRI". Publications from conferences, monographs, theses, or reference lists in identified studies were also regarded as potential sources to be included in the meta-analysis.

Inclusion and exclusion criteria
--------------------------------

According to the PRISMA guidelines,[@b9-ndt-15-721] the following criteria were used for inclusion in the meta-analysis: 1) original research published in peer-reviewed journals, conferences, or monographs; 2) scanning methods were structural (structural magnetic resonance imaging, sMRI); 3) studies comparing the brain structure in individuals with different genotypes of rs1344706 in the *ZNF804A* gene; 4) for Anisotropic Effect-Size Signed Differential Mapping (AES-SDM) analysis, the coordinates (either Talairach or Montreal Neurological Institute) of altered brain regions were detailed; 5) for Comprehensive Meta-Analysis (CMA), the effect size of different brain regions was listed as *F*, *t*, *z*, or *P*-values; 6) the publication was in English. Meanwhile, the following studies were excluded: 1) studies with region of interest (ROI) approaches and 2) studies not performed using sMRI. Two researchers (SW and ZC) examined the abstract or full text of all searched articles to identify studies that fit the abovementioned criteria. When multiple studies used the same individual cohort, the one with the largest sample size was selected.

Data extraction and quality scores
----------------------------------

Two researchers (SW and YH) independently extracted the basic data, including 1) general characteristics such as first author and year of publication; 2) samples' information such as individuals (schizophrenia or healthy controls), race, sample size, age, and gender; 3) genetic data such as distribution of genotypes and alleles of rs1344706; and 4) imaging data such as tesla of magnetic resonance imaging (MRI) and full width at half-maximum. We also obtained voxel-based data, which included the peak coordinates and effect size of statistically significant differences of brain structure. Missing data were acquired from the corresponding authors of the study by e-mail. If missing data could not be acquired, the studies were excluded. Any disagreement about the data was resolved through group discussions with consensus. All data were checked for internal consistency. The quality of the included studies was evaluated using a checklist that focused on both the clinical and demographic aspects of individual study samples and the imaging-specific methodology used in the studies. We also adopted recently established preprocessing and computational parameters.

AES-SDM analysis
----------------

The meta-analysis of sMRI studies was performed using AES-SDM software, which has been previously used in several neuropsychiatric disorders.[@b10-ndt-15-721] AES-SDM software is a voxel-based meta-analytic approach that enables the use of reported peak coordinates of gray and white matter difference in whole brain studies.[@b11-ndt-15-721] The AES-SDM method has been previously described.[@b12-ndt-15-721]

Two researchers (SW and YH) performed the meta-analysis. The main threshold was set at uncorrected *P*\<0.001 (empirically equivalent to *P*\<0.05, corrected) with *z* score \>1 (peak height) and cluster extent ≥20 voxels. The default settings in the AES-SDM software were used for other parameters. A leave-one-out jackknife analysis was used to determine the sensitivity of the reported results to the inclusion of individual studies. Heterogeneity among studies was assessed through the *Q* statistic with a threshold of *P*\<0.05.

CMA
---

Some studies failed to provide the differential peak coordinates for the AES-SDM analysis. To integrate more data, we further analyzed the differences of brain structure between *ZNF804A* gene rs1344706 carriers and noncarriers with CMA software. Statistical effect value was set as *Z*. The heterogeneity of the results was assessed with the *I*^2^ statistic using the chi-squared test at *a*=0.1. When *I*^2^≤50%, it was considered that there was no heterogeneity, and the fixed-effect model was used for the meta-analysis. Otherwise, the studies were considered to involve significant heterogeneity, and the random-effect model was used. Publication bias was tested using Egger's test. Then, *P*\<0.05 was used to denote statistical significance.

Results
=======

Basic information of included studies
-------------------------------------

The entire search process is as described in the quorum-type flowchart ([Figure 1](#f1-ndt-15-721){ref-type="fig"}). Seventeen studies[@b7-ndt-15-721],[@b8-ndt-15-721],[@b13-ndt-15-721]--[@b27-ndt-15-721] on brain structure met the inclusion criteria, and one[@b14-ndt-15-721] of which involved both gray matter and white matter. The overall sample was equivalent to a cohort of 1,031 schizophrenia patients and 3,416 healthy controls. The general, genotype, and scanning information and quality scores of each study are summarized in [Tables 1](#t1-ndt-15-721){ref-type="table"} and [2](#t2-ndt-15-721){ref-type="table"}.

Significant genetic--neuroimaging associations in AES-SDM
---------------------------------------------------------

Six studies on gray matter containing peak coordinates were included in this part of AES-SDM analysis. For healthy controls, rs1344706 risk allele carriers had decreased gray matter in the left superior temporal gyrus (*z*=−2.299, *P*=0.00027) and left median network (*z*=−1.949, *P*=0.00076) compared with noncarriers. However, for schizophrenia patients, the risk allele carriers had increased gray matter in the right inferior frontal gyrus (*z*=2.634, *P*=0.00019) and left superior temporal gyrus (*z*=2.479, *P*=0.00033) compared with noncarriers. The AES-SDM results of gray matter are summarized in [Table 3](#t3-ndt-15-721){ref-type="table"} and [Figure 2](#f2-ndt-15-721){ref-type="fig"}.

Two studies on white matter containing peak coordinates were included in this part of AES-SDM analysis. For healthy controls, rs1344706 risk allele carriers had decreased white matter integrity in the left median network (*z*=−1.100, *P*=0.00005) and corpus callosum (*z*=−1.099, *P*=0.00005) compared with noncarriers. However, no study involved schizophrenia patients. The AES-SDM results of white matter are summarized in [Table 4](#t4-ndt-15-721){ref-type="table"} and [Figure 3](#f3-ndt-15-721){ref-type="fig"}.

Significant genetic--neuroimaging associations in CMA
-----------------------------------------------------

Seventeen studies containing effect sizes were included in the CMA analysis. For healthy controls, rs1344706 risk allele carriers had decreased gray matter in the frontal (*z*=−2.008, *P*=0.045), temporal (*z*=−6.099, *P*=0.000), and occipital (*z*=−3.106, *P*=0.002) areas compared with noncarriers. However, for schizophrenia patients, the risk allele carriers had increased gray matter in the frontal (*z*=3.445, *P*=0.001), temporal (*z*=2.140, *P*=0.032), parietal (*z*=5.346, *P*=0.000), occipital (*z*=3.605, *P*=0.000), limbic system (*z*=4.765, *P*=0.000), and basal nucleus (*z*=4.689, *P*=0.000) areas compared with noncarriers. In addition, there was no difference in white matter between the rs1344706 risk allele carriers and noncarriers in both patients and healthy individuals. The CMA results are summarized in [Table 5](#t5-ndt-15-721){ref-type="table"}.

Discussion
==========

In this meta-analysis, AES-SDM software and CMA software were used to integrate the 17 studies and determine the association between *ZNF804A* gene rs1344706 polymorphism and brain structure. The present study not only analyzed mental disorders with schizophrenia but also included healthy individuals. In the AES-SDM analysis, only a part of the eligible studies were included due to the limitations of peak coordinates in the original literature. We found that schizophrenia patients carrying the risk allele of rs1344706 in *ZNF804A* had a larger gray matter in the right inferior frontal gyrus and the left superior temporal gyrus compared with noncarriers. Conversely, healthy controls with risk alleles had a smaller gray matter in the left superior temporal gyrus and left median network. It is important to note that the risk allele of rs1344706 has a completely opposite effect on the left superior temporal gyrus in different populations. In terms of white matter, the AES-SDM meta-analysis concluded that the white matter integrity was lower in healthy controls carrying the risk allele of rs1344706, including the left median network and corpus callosum compared with noncarriers. However, for schizophrenia patients, there are not enough data to conduct this meta-analysis.

To further verify the association, we then analyzed the included studies using the CMA method. This method allows more data (effect size) to be entered in the meta-analysis, but it cannot determine the precise brain area. The final result suggests that the risk allele of rs1344706 carriers in healthy controls had a smaller gray matter in the frontal and temporal lobes. Conversely, for schizophrenia patients, the risk allele carriers had larger gray matter in the frontal lobe, temporal lobe, parietal lobe, occipital lobe, limbic system, and basal nuclei. These results were basically consistent with those obtained using the AES-SDM method. However, the results of CMA did not suggest that the rs1344706 risk allele had any significant association with the white matter.

Compared with previous reports, the results of this meta-analysis are basically consistent with most of the studies. However, the results of the study by Wei et al[@b21-ndt-15-721] showed that the risk allele had negative effects on brain structure (including cortical thickness, surface area, and volume) in schizophrenia patients. On the contrary, positive effects were found in healthy controls. Similarly, Voineskos et al[@b14-ndt-15-721] believed that the risk allele of rs1344706 plays a positive role on the gray matter in healthy controls. In addition, Wassink et al[@b8-ndt-15-721] found that the risk allele of rs1344706 had negative effects on brain structure in both healthy controls and schizophrenia patients. We speculated that the differences might come from the different baselines of the included samples. Furthermore, the ethnic difference of the subjects might contribute to the discriminate distribution frequency of rs1344706 allele and further affected the results of association studies.

The prevailing results of our meta-analysis and previous studies showed that the risk allele of rs1344706 in *ZNF804A* had opposite effects on the brain structure in mental disorders such as schizophrenia (positive) and healthy individuals (negative). It may be due to different genetic variations or genetic environment in subjects.[@b28-ndt-15-721],[@b29-ndt-15-721] For example, Guella et al[@b30-ndt-15-721] found that the A allele of rs12476147 in exon 4 of *ZNF804A* is overexpressed in the dorsolateral prefrontal cortex of individuals heterozygous for rs1344706. Furthermore, this allele of rs12476147 could increase the risk of schizophrenia. In the same study, the risk allele of rs1344706 was found to be a cis-regulatory variant that could directly lead to an imbalance of this allele expression in adult cerebral cortex.[@b30-ndt-15-721] Therefore, the different effects of rs1344706 on schizophrenia patients and healthy individuals may be related to the neuropathological mechanism of this risk variant. The increased gray matter in risk allele carriers may give the suggestion of the risk allele participation in schizophrenia and the brain changes of the patients.

Imaging genetic study is generally designed to assess the impact of specific risk genes (or risk scores) on brain structure. However, it is unclear how gene expression or gene products affect the brain structure and function. Several variants have been forthcoming in schizophrenia, in particular *ZNF804A*, located in the major histocompatibility complex. The strongest support is *ZNF804A*, encoding a zinc finger protein of unknown, but possibly regulatory function.[@b31-ndt-15-721] An increasing number of evidence shows that the genetic effect on the brain begins at the early stages of neural development.[@b32-ndt-15-721] The rs1344706 polymorphism affects the expression of *ZNF804A* in the brain during embryonic development, but this effect does not exist in the adult brain.[@b32-ndt-15-721] However, autopsy studies found that *ZNF804A* expression is different in schizophrenia patients and healthy controls.[@b33-ndt-15-721],[@b34-ndt-15-721] These findings directly or indirectly demonstrate that there is a relationship between *ZNF804A* expression and brain development. However, the mechanisms of a given polymorphism impacting specific brain regions need further exploration.

Finally, the present meta-analysis has heterogeneity and publication bias in the discussion of some indicators. The greatest source of heterogeneity may come from the studies with opposite data. In addition, differences in the scan parameters and analytical indicators may also increase the heterogeneity. The trim and fill processes did not change the general result (although the strength of the association was slightly attenuated), suggesting that the association is not an artifact of unpublished negative studies. Nevertheless, that possibility is not fully excluded by this method. The unpublished articles in other languages have not been included in this meta-analysis and may result in publication bias. In general, the meta-analysis further confirmed the influence of the risk allele of *ZNF804A* gene rs1344706 on the brain structure and provided further insight into the genetic-related pathogenesis of psychiatric disorders such as schizophrenia.

Conclusion
==========

Abnormalities on brain structure have a strong relationship with *ZNF804A* gene rs1344706 polymorphism, but the association may be different in healthy individuals and those with mental disorders. The risk allele of rs1344706 has a positive effect on brain structure in schizophrenia patients. However, this allele has a negative effect on brain structure in healthy individuals.
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![AES-SDM results of the effect of risk allele on gray matter.\
**Notes:** Regions highlighted in red signify increased gray matter in schizophrenia patients carrying risk allele compared with noncarriers. Regions highlighted in blue signify decreased gray matter in healthy individuals carrying risk allele compared with noncarriers.\
**Abbreviation:** AES-SDM, Anisotropic Effect-Size Signed Differential Mapping.](ndt-15-721Fig2){#f2-ndt-15-721}

![AES-SDM results of the effect of risk allele on white matter.\
**Note:** Regions highlighted in blue signify decreased white matter integrity in healthy individuals carrying risk allele compared with noncarriers.\
**Abbreviation:** AES-SDM, Anisotropic Effect-Size Signed Differential Mapping.](ndt-15-721Fig3){#f3-ndt-15-721}

###### 

General characteristics of the included studies

  Study                              Year of publication   Population (n)   Age (years)   Gender (male, n)   Ancestry    Medication   Genotype distribution                        
  ---------------------------------- --------------------- ---------------- ------------- ------------------ ----------- ------------ ----------------------- -------------- ----- -----
  **Gray matter**                                                                                                                                                                  
  Lencz et al[@b7-ndt-15-721]        2010                  HC (39)          34.4          19                 Caucasian   --           18                      14             7     Yes
  Donohoe et al[@b13-ndt-15-721]     2011                  SZ (70)          40.4          46                 Caucasian   Yes          27                      30             13    Yes
                                                           HC (38)          32.5          20                 Caucasian   --           19                      14             5     Yes
  Voineskos et al[@b14-ndt-15-721]   2011                  HC (62)          37.4          40                 Caucasian   --           23                      33             6     Yes
  Cousijn et al[@b15-ndt-15-721]     2012                  HC (892)         22.8          369                Caucasian   --           297                     434            160   Yes
  Wassink et al[@b8-ndt-15-721]      2012                  SZ (335)         31.7          248                Caucasian   Yes          126                     165            44    NS
                                                           HC (198)         30.7          103                Caucasian   --           69                      105            24    NS
  Wei et al[@b16-ndt-15-721]         2012                  SZ (80)          26.6          45                 Chinese     Yes          15                      46             19    Yes
                                                           HC (69)          25.4          39                 Chinese     --           22                      35             12    Yes
  Bergmann et al[@b17-ndt-15-721]    2013                  SZ (82)          34.2          49                 Caucasian   Yes          NS                      NS             NS    NS
                                                           HC (152)         35.9          79                 Caucasian   --           NS                      NS             NS    NS
  Schultz et al[@b18-ndt-15-721]     2014                  SZ (55)          29.3          NS                 Caucasian   Yes          20                      35 (AC + CC)   NS    
                                                           HC (40)          27.3          NS                 Caucasian   --           15                      25 (AC + CC)   NS    
  Cousijn et al[@b20-ndt-15-721]     2015                  HC (1,300)       22.9          43                 Caucasian   --           NS                      NS             NS    NS
  Nenadic et al[@b19-ndt-15-721]     2015                  SZ (62)          31.6          44                 Caucasian   Yes          23                      33             6     Yes
                                                           HC (54)          29.5          29                 Caucasian   --           19                      28             7     Yes
  Wei et al[@b21-ndt-15-721]         2015                  SZ (59)          26.3          31                 Chinese     No           26                      16             17    Yes
                                                           HC (60)          25.6          33                 Chinese     --           38                      12             10    Yes
  **White matter**                                                                                                                                                                 
  Voineskos et al[@b14-ndt-15-721]   2011                  HC (62)          37.4          40                 Caucasian   --           23                      33             6     Yes
  Kuswanto et al[@b22-ndt-15-721]    2012                  SZ (125)         34.3          90                 Chinese     Yes          26                      53             32    Yes
                                                           HC (75)          31.9          48                 Chinese     --           11                      37             19    Yes
  Sprooten et al[@b23-ndt-15-721]    2012                  HC (50)          22.7          25                 Caucasian   --           19                      24             7     Yes
  Wei et al[@b24-ndt-15-721]         2013                  SZ (100)         26.5          53                 Chinese     Yes          18                      58             24    Yes
                                                           HC (69)          25.4          39                 Chinese     --           22                      35             12    Yes
  Ikuta et al[@b25-ndt-15-721]       2014                  HC (107)         31.8          56                 Caucasian   --           43                      42             22    NS
  Mallas et al[@b26-ndt-15-721]      2016                  SZ (63)          33.8          50                 Mixed       Yes          27                      28             8     Yes
                                                           HC (124)         35.8          67                 Mixed       --           59                      51             14    Yes
  Zhang et al[@b27-ndt-15-721]       2016                  HC (87)          27.6          68                 Chinese     --           23                      43             21    Yes

**Abbreviations:** HC, healthy control; SZ, schizophrenia.

###### 

Scanning characteristics and quality assessment of the included studies

  Study                              Year of publication   fMRI information Tesla FWHM (mm) Task Indices   Quality                        
  ---------------------------------- --------------------- ----------------------------------------------- --------- ------ ------------- --------
                                                                                                                                          
  **Gray matter**                                                                                                                         
  Lencz et al[@b7-ndt-15-721]        2010                  1.5                                             NS        None   GM, WM, CSF   High
  Donohoe et al[@b13-ndt-15-721]     2011                  1.5                                             8         None   GM            High
  Voineskos et al[@b14-ndt-15-721]   2011                  1.5                                             NS        None   CT            High
  Cousijn et al[@b15-ndt-15-721]     2012                  1.5, 3.0                                        8         None   GM, WM        High
  Wassink et al[@b8-ndt-15-721]      2012                  1.5                                             NS        None   GM, WM, CSF   High
  Wei et al[@b16-ndt-15-721]         2012                  1.5                                             12        None   WM            High
  Bergmann et al[@b17-ndt-15-721]    2013                  1.5                                             30        None   CT            Medium
  Schultz et al[@b18-ndt-15-721]     2014                  1.5                                             NS        None   CT, CF        Medium
  Cousijn et al[@b20-ndt-15-721]     2015                  1.5                                             NS        None   GM, WM        Medium
  Nenadic et al[@b19-ndt-15-721]     2015                  1.5                                             12        None   GM, WM        High
  Wei et al[@b21-ndt-15-721]         2015                  1.5                                             10        None   CT, CSA, CV   High
  **White matter**                                                                                                                        
  Voineskos et al[@b14-ndt-15-721]   2011                  1.5                                             None      None   FA            High
  Kuswanto et al[@b22-ndt-15-721]    2012                  3                                               None      None   FA            High
  Sprooten et al[@b23-ndt-15-721]    2012                  1.5                                             None      None   FA, MD        High
  Wei et al[@b24-ndt-15-721]         2013                  1.5                                             None      None   FA, MD        High
  Ikuta et al[@b25-ndt-15-721]       2014                  3                                               None      None   FA            High
  Mallas et al[@b26-ndt-15-721]      2016                  1.5                                             None      None   FA            High
  Zhang et al[@b27-ndt-15-721]       2016                  3                                               None      None   FA            High

**Abbreviations:** fMRI, functional magnetic resonance imaging; FWHM, full width at half-maximum; NS, not stated; GM, gray matter; WM, white matter; CSF, cerebrospinal fluid; CT, cortical thickness; CF, cortical fold; CSA, cortical surface area; CV, cortical volume; FA, fractional anisotropy; MD, mean diffusivity.

###### 

Influence of *ZNF804A* rs1344706 on gray matter (AES-SDM)

  Brain region                                           Peak coordinate   Cluster                                  
  ------------------------------------------------------ ----------------- --------- ----- -------- --------- ----- ----------------------
                                                                                                                    
  **Positive effects of rs1344706 risk alleles in HC**                                                              
  None                                                                                                              
  **Negative effects of rs1344706 risk alleles in HC**                                                              
  Left superior temporal gyrus                           −60               26        10    −2.299   0.00027   252   BA21 (93)
                                                                                                                    BA22 (89)
                                                                                                                    BA22 (25)
                                                                                                                    Corpus callosum (18)
  Left median network, cingulum                          −4                −22       34    −1.949   0.00076   52    BA23 (29)
  **Positive effects of rs1344706 risk alleles in SZ**                                                              
  Right inferior frontal gyrus                           44                22        −12   2.634    0.00019   248   BA38 (102)
                                                                                                                    BA47 (52)
                                                                                                                    BA48 (29)
                                                                                                                    BA48 (13)
  Left superior temporal gyrus                           −54               −6        6     2.479    0.00033   83    BA48 (59)
                                                                                                                    BA48 (17)
  **Negative effects of rs1344706 risk alleles in SZ**                                                              
  None                                                                                                              

**Abbreviations:** AES-SDM, Anisotropic Effect-Size Signed Differential Mapping; MNI, Montreal Neurological Institute.

###### 

Influence of *ZNF804A* rs1344706 on white matter (AES-SDM)

  Brain region                                     Peak coordinate   Cluster size in voxels                           
  ------------------------------------------------ ----------------- ------------------------ ---- -------- --------- ----
                                                                                                                      
  **Positive effects of rs1344706 risk alleles**                                                                      
  None                                                                                                                
  **Negative effects of rs1344706 risk alleles**                                                                      
  Left median network, cingulum                    −16               42                       8    −1.100   0.00005   59
  Corpus callosum                                  2                 8                        24   −1.099   0.00005   52
                                                   20                −42                      36   −1.101   0.00001   45

**Abbreviations:** AES-SDM, Anisotropic Effect-Size Signed Differential Mapping; MNI, Montreal Neurological Institute.

###### 

Influence of *ZNF804A* rs1344706 on brain structure (CMA)

  Indices        Region          Population   Model    Effect size   Heterogeneity   Egger's regression intercept   Publication bias                                     
  -------------- --------------- ------------ -------- ------------- --------------- ------------------------------ ------------------ -------- ------- -------- ------- -----
  Gray matter    Frontal         HC           Random   −2.008        0.045           −0.740                         −1.463\~--0.018    89.022   0.000   15.644   0.004   Yes
                                 SZ           Fixed    3.445         0.001           0.778                          0.336\~1.221       60.166   0.057   1.185    0.358   No
                 Temporal        HC           Fixed    −6.099        0.000           −0.958                         −1.266\~--0.650    17.898   0.301   2.967    0.097   No
                                 SZ           Random   2.140         0.032           0.302                          0.025\~0.579       89.678   0.000   0.120    0.916   No
                 Parietal        SZ           Fixed    5.346         0.000           1.124                          0.712\~1.537       0.000    0.923   --       --      --
                 Occipital       HC           Fixed    −3.106        0.002           −0.631                         −1.030\~--0.233    33.581   0.220   --       --      --
                                 SZ           Fixed    3.605         0.000           0.748                          0.342\~1.155       54.182   0.140   --       --      --
                 Limbic system   HC           Random   −1.485        0.138           −0.900                         −2.087\~0.288      93.838   0.000   11.921   0.053   No
                                 SZ           Fixed    4.765         0.000           0.939                          0.553\~1.325       0.000    0.631   --       --      --
                 Basal nuclei    SZ           Fixed    4.689         0.000           0.952                          0.554\~1.350       0.000    0.869   --       --      --
  White matter   All             HC           Random   0.081         0.936           0.018                          −0.430\~0.467      80.609   0.000   1.325    0.256   No
                                 SZ           Random   −0.295        0.768           −0.087                         −0.667\~0.492      79.300   0.008   4.468    0.140   No

**Abbreviations:** CMA, Comprehensive Meta-Analysis; HC, healty control; SZ, schizophrenia.
